Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.
VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped...
Main Authors: | Blandine Patillon, Pierre Luisi, Hélène Blanché, Etienne Patin, Howard M Cann, Emmanuelle Génin, Audrey Sabbagh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3532425?pdf=render |
Similar Items
-
Genetic determinants of indirect anticoagulants’ sensitivity: VKORC1 and APOE gene polymorphism
by: D. A. Sychev, et al.
Published: (2005-10-01) -
Genetic determinants of indirect anticoagulants’ sensitivity: VKORC1 and APOE gene polymorphism
by: D. A. Sychev, et al.
Published: (2005-10-01) -
Distribution and frequency of VKORC1 sequence variants conferring resistance to anticoagulants in Mus musculus
by: Pelz, H.-J., et al.
Published: (2011-10-01) -
Investigation of the current status of anticoagulant resistance in UK Norway rats by VKORC1 genotyping
by: Clarke, D. J., et al.
Published: (2011-10-01) -
Anticoagulant resistance in Norway rats conferred by VKORC1 mutations in south-east England
by: Rymer, Dave J.
Published: (2017)